COVID-19: Nigeria won’t suspend hydroxychloroquine trial — NAFDAC

COVID-19: Nigeria won’t suspend hydroxychloroquine trial — NAFDAC

Premium Times Nigeria

Published

The announcement comes a day after the WHO announced a temporary suspension of hydroxychloroquine trials.

The post COVID-19: Nigeria won’t suspend hydroxychloroquine trial — NAFDAC appeared first on Premium Times Nigeria.

Full Article